These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 35982495)
21. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease. Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042 [TBL] [Abstract][Full Text] [Related]
22. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes. Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490 [TBL] [Abstract][Full Text] [Related]
23. Delayed heart rate recovery after exercise as a risk factor of incident type 2 diabetes mellitus after adjusting for glycometabolic parameters in men. Yu TY; Jee JH; Bae JC; Hong WJ; Jin SM; Kim JH; Lee MK Int J Cardiol; 2016 Oct; 221():17-22. PubMed ID: 27400291 [TBL] [Abstract][Full Text] [Related]
24. High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. Garcia E; Osté MCJ; Bennett DW; Jeyarajah EJ; Shalaurova I; Gruppen EG; Hazen SL; Otvos JD; Bakker SJL; Dullaart RPF; Connelly MA J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683780 [TBL] [Abstract][Full Text] [Related]
25. Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits. Zhu W; Wang S; Dai H; Xuan L; Deng C; Wang T; Zhao Z; Li M; Lu J; Xu Y; Chen Y; Wang W; Bi Y; Xu M; Ning G J Diabetes; 2020 Aug; 12(8):616-625. PubMed ID: 32220107 [TBL] [Abstract][Full Text] [Related]
26. Association between Plasma Trimethylamine N-Oxide Levels and Type 2 Diabetes: A Case Control Study. Kalagi NA; Thota RN; Stojanovski E; Alburikan KA; Garg ML Nutrients; 2022 May; 14(10):. PubMed ID: 35631234 [TBL] [Abstract][Full Text] [Related]
27. Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation. Luciani M; Müller D; Vanetta C; Diteepeng T; von Eckardstein A; Aeschbacher S; Rodondi N; Moschovitis G; Reichlin T; Sinnecker T; Wuerfel J; Bonati LH; Saeedi Saravi SS; Chocano-Bedoya P; Coslovsky M; Camici GG; Lüscher TF; Kuehne M; Osswald S; Conen D; Beer JH; Heart; 2023 Feb; 109(5):396-404. PubMed ID: 36593094 [TBL] [Abstract][Full Text] [Related]
28. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke. Sun T; Zhang Y; Yin J; Peng X; Zhou L; Huang S; Wen Y; Cao B; Chen L; Li X; Yang W; Tan A; Cheng J; Liu L J Atheroscler Thromb; 2021 Apr; 28(4):320-328. PubMed ID: 32641646 [TBL] [Abstract][Full Text] [Related]
29. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients. Nie J; Xie L; Zhao BX; Li Y; Qiu B; Zhu F; Li GF; He M; Wang Y; Wang B; Liu S; Zhang H; Guo H; Cai Y; Huo Y; Hou FF; Xu X; Qin X Stroke; 2018 Sep; 49(9):2021-2028. PubMed ID: 30354996 [TBL] [Abstract][Full Text] [Related]
30. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke. Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326 [No Abstract] [Full Text] [Related]
31. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. Shea JW; Jacobs DR; Howard AG; Lulla A; Lloyd-Jones DM; Murthy VL; Shah RV; Trujillo-Gonzalez I; Gordon-Larsen P; Meyer KA Am J Clin Nutr; 2024 Jan; 119(1):29-38. PubMed ID: 37865185 [TBL] [Abstract][Full Text] [Related]
32. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Wang T; Lu J; Shi L; Chen G; Xu M; Xu Y; Su Q; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Zhao Z; Chen Y; Yan L; Qin G; Wan Q; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Lai S; Bi Y; DeFronzo RA; Wang W; Ning G; Lancet Diabetes Endocrinol; 2020 Feb; 8(2):115-124. PubMed ID: 31879247 [TBL] [Abstract][Full Text] [Related]
33. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population. Zheng L; Zheng J; Xie Y; Li Z; Guo X; Sun G; Sun Z; Xing F; Sun Y Atherosclerosis; 2019 Jan; 280():126-131. PubMed ID: 30508691 [TBL] [Abstract][Full Text] [Related]
34. Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis. Fu D; Shen J; Li W; Wang Y; Zhong Z; Ye H; Huang N; Fan L; Yang X; Yu X; Zhou Y; Mao H Blood Purif; 2021; 50(6):837-847. PubMed ID: 33596582 [TBL] [Abstract][Full Text] [Related]
35. Trimethylamine N-oxide predicts cardiovascular events in coronary artery disease patients with diabetes mellitus: a prospective cohort study. Yu X; Wang Y; Yang R; Wang Z; Wang X; Wang S; Zhang W; Dong J; Chen W; Ji F; Gao W Front Endocrinol (Lausanne); 2024; 15():1360861. PubMed ID: 39092284 [TBL] [Abstract][Full Text] [Related]
36. Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort. Gessner A; di Giuseppe R; Koch M; Fromm MF; Lieb W; Maas R Clin Chem Lab Med; 2020 Apr; 58(5):733-740. PubMed ID: 32084001 [TBL] [Abstract][Full Text] [Related]
37. Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method. Tang Y; Zou Y; Cui J; Ma X; Zhang L; Yu S; Qiu L Clin Chim Acta; 2022 Nov; 536():162-168. PubMed ID: 36191613 [TBL] [Abstract][Full Text] [Related]
38. Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis. Chang D; Xu X; Yang Z; Ma T; Nie J; Dong J Perit Dial Int; 2022 Nov; 42(6):622-630. PubMed ID: 34724845 [TBL] [Abstract][Full Text] [Related]
39. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria. Winther SA; Øllgaard JC; Hansen TW; von Scholten BJ; Reinhard H; Ahluwalia TS; Wang Z; Gæde P; Parving HH; Hazen S; Pedersen O; Rossing P PLoS One; 2021; 16(3):e0244402. PubMed ID: 33657115 [TBL] [Abstract][Full Text] [Related]